On April 16, 2025, Assort Health, a leading AI platform for managing specialty-specific patient phone calls, announced the successful completion of a $22 million Series A funding round. The round was co-led by First Round Capital and Chemistry, with additional support from existing partner Quiet Capital. They join Assort Health’s existing backers, including Four Acres, Tau Ventures, and several notable angel investors, such as senior executives and founders from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto. Wilson Sonsini Goodrich & Rosati advised Assort Health on the transaction.

Founded in 2023, Assort Health is tackling persistent challenges in call center scheduling that contribute to high staff turnover and lengthy wait times. The company's AI-powered voice agents are already optimizing operations to improve patient access for leading organizations across the United States.

The Wilson Sonsini team that advised on the transaction included Lang Liu, Alex Youssef, and Madisyn Klein.

For more information, please see Assort Health’s press release. Additional coverage can be found at Fortune and Yahoo Finance.